Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM PAR
-
Total 13F shares
-
256,711
-
Share change
-
+3,218
-
Total reported value
-
$1,251,000
-
Price per share
-
$4.87
-
Number of holders
-
11
-
Value change
-
+$15,585
-
Number of buys
-
3
-
Number of sells
-
1
Institutional Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q4 2014
As of 31 Dec 2014,
IMMUCELL CORP /DE/ - COM PAR (ICCC) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
256,711 shares.
The largest 10 holders included
HealthInvest Partners AB, SHUFRO ROSE & CO LLC, GRT CAPITAL PARTNERS LLC, Essex Financial Services, Inc., RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, UBS Group AG, and Tower Research Capital LLC (TRC).
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.